Latest updates on the coronavirus and heart disease
Last week, we had to take the difficult decision to cancel ACC.20/WCC in Chicago. This was absolutely the right decision given the need for cardiovascular clinicians around the world to be on the front lines helping patients and their communities address COVID-19.
Since then, the ACC.20/WCC team has been hard at work creating a virtual experience that leverages new technologies, educational formats, and more to bring ACC.20/WCC science and education directly to cardiovascular clinicians and other key stakeholders worldwide.
The free ACC.20/WCC Virtual experience will kick off on Saturday, 28 March and will offer three days of science and learning. The meeting will feature “live” access to 23 education sessions including Late-Breaking Clinical Trials, Featured Clinical Research, Young Investigator Awards, and Keynotes.
We encourage you to mark your calendars and join us in real-time for all the events and engage in conversations on social media (#ACC20 / #WCCardio). Not able to attend? The sessions and presentations will be archived for future viewing.
More details on other exciting activities, as well as how to get involved, will be coming over the next week and posted to the ACC.20/WCC website.
We are excited about the opportunity to use this bigger and broader stage to provide the important, practice-changing science and education that is even more necessary now than ever before.
The Uganda Heart-Research Foundation develops treatment guidelines for common CVD conditions in Uganda
A World Health Assembly Like No Other
PHFI announces eLearning courses 2020-2021 on Health Promotion and Tobacco Control